These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 9706493

  • 41. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci.
    Pitot HC, Goldsworthy TL, Moran S, Kennan W, Glauert HP, Maronpot RR, Campbell HA.
    Carcinogenesis; 1987 Oct; 8(10):1491-9. PubMed ID: 2888545
    [Abstract] [Full Text] [Related]

  • 42. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 43. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
    [Abstract] [Full Text] [Related]

  • 44. Low dose DDT inhibition of hepatocarcinogenesis initiated by diethylnitrosamine in male rats: possible mechanisms.
    Kushida M, Sukata T, Uwagawa S, Ozaki K, Kinoshita A, Wanibuchi H, Morimura K, Okuno Y, Fukushima S.
    Toxicol Appl Pharmacol; 2005 Nov 01; 208(3):285-94. PubMed ID: 15885732
    [Abstract] [Full Text] [Related]

  • 45. Rapid bioassay methods for carcinogens and modifiers of hepatocarcinogenesis.
    Ito N, Imaida K, Hasegawa R, Tsuda H.
    Crit Rev Toxicol; 1989 Nov 01; 19(4):385-415. PubMed ID: 2663023
    [Abstract] [Full Text] [Related]

  • 46. Initiation-promotion-initiation. Induction of neoplastic foci within islands of precancerous liver cells in the rat.
    Scherer E, Feringa AW, Emmelot P.
    IARC Sci Publ; 1984 Nov 01; (56):57-66. PubMed ID: 6536610
    [Abstract] [Full Text] [Related]

  • 47. A histological study of the promotive effect of diethylstilbestrol on diethylnitrosamine initiated carcinogenesis of liver in rat.
    Ding L, Zou DY, Chen JY, Wang JT, Wang YB, Pan SR, Wand SH.
    Pathol Res Pract; 1984 Mar 01; 178(4):339-44. PubMed ID: 6328461
    [Abstract] [Full Text] [Related]

  • 48. Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1992 Mar 01; 407():1-289. PubMed ID: 12621523
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Quantitative aspects of drug-mediated tumour promotion in liver and its toxicological implications.
    Kunz W, Schaude G, Schwarz M, Tennekes H.
    Carcinog Compr Surv; 1982 Mar 01; 7():111-25. PubMed ID: 7039825
    [No Abstract] [Full Text] [Related]

  • 51. Phenobarbital-induced cytoplasmic accumulation of beta1-integrin in rat liver enzyme altered foci; an immunohistological study.
    Stenius U, Högberg J.
    Cancer Lett; 1998 Dec 11; 134(1):103-9. PubMed ID: 10381136
    [Abstract] [Full Text] [Related]

  • 52. Promotion mechanism of phenobarbital and partial hepatectomy in DENA hepatocarcinogenesis cell kinetics effect.
    Barbason H, Rassenfosse C, Betz EH.
    Br J Cancer; 1983 Apr 11; 47(4):517-25. PubMed ID: 6849796
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Occurrence of progressive DNA damage coincident with the appearance of foci of altered hepatocytes.
    Stout DL, Becker FF.
    Carcinogenesis; 1982 Apr 11; 3(6):599-602. PubMed ID: 6126282
    [Abstract] [Full Text] [Related]

  • 55. Kinetics of induction and growth of enzyme-deficient islands involved in hepatocarcinogenesis.
    Scherer E, Emmelot P.
    Cancer Res; 1976 Jul 11; 36(7 PT 2):2544-54. PubMed ID: 132270
    [Abstract] [Full Text] [Related]

  • 56. Molecular profiling of genes up-regulated during promotion by phenobarbital treatment in a medium-term rat liver bioassay.
    Shibutani M, Takahashi N, Kobayashi T, Uneyama C, Masutomi N, Nishikawa A, Hirose M.
    Carcinogenesis; 2002 Jun 11; 23(6):1047-55. PubMed ID: 12082028
    [Abstract] [Full Text] [Related]

  • 57. 1 alpha,25-Dihydroxyvitamin D(3) inhibits rat liver ultrastructural changes in diethylnitrosamine-initiated and phenobarbital promoted rat hepatocarcinogenesis.
    Basak R, Bhattacharya R, Chatterjee M.
    J Cell Biochem; 2001 Mar 26; 81(2):357-67. PubMed ID: 11241675
    [Abstract] [Full Text] [Related]

  • 58. [The sensitivity of carcinogenic initiation effect of regenerated liver induced by diethylnitrosamine in rats].
    Han G, Chen J, Ding L.
    Zhonghua Bing Li Xue Za Zhi; 1998 Feb 26; 27(1):23-6. PubMed ID: 11244937
    [Abstract] [Full Text] [Related]

  • 59. Nuclear lesions during rat hepatocarcinogenesis. II. Measuring the micronuclei during initiation, promotion and progression of rat hepatocarcinogenesis induced with diethylnitrosamine.
    Herens C, Massart S, Bouzahzah B, Koulischer L, Barbason H.
    Mutat Res; 1995 Jul 26; 329(2):161-71. PubMed ID: 7603498
    [Abstract] [Full Text] [Related]

  • 60. The tumor promoting effect of constant light exposure on diethylnitrosamine-induced hepatocarcinogenesis in rats.
    van den Heiligenberg S, Deprés-Brummer P, Barbason H, Claustrat B, Reynes M, Lévi F.
    Life Sci; 1999 Jul 26; 64(26):2523-34. PubMed ID: 10403512
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.